Download full release - University Hospitals Newsroom

Date:
Contacts:
Sept. 1, 2016
Alicia Reale, University Hospitals
216-844-5158
Marc Kaplan, Case Western
Reserve University School of Medicine
216-368-4692
Researchers find gene mutations lead to more aggressive
colorectal cancer in African American patients
15 gene mutations lead to higher recurrence and metastasis; genes may contribute to lower survival
rates seen in African Americans
CLEVELAND – Case Comprehensive Cancer Center researchers, a research collaboration which includes
University Hospitals Seidman Cancer Center and Case Western Reserve University, who last year identified new
gene mutations unique to colon cancers in African Americans, have found that tumors with these mutations are
highly aggressive and more likely to recur and metastasize. These findings partly may explain why African
Americans have the highest incidence and death rates of any group for this disease.
The study is published online (http://jnci.oxfordjournals.org/content/108/12/djw164.full.pdf+html) and will
be printed in the December 2016 issue of the Journal of the National Cancer Institute (JNCI) by members of a
research team that a year ago found 15 genes in African Americans that are rarely or never detected as mutated
in colon cancers from Caucasians. The current study investigated the outcomes associated with these mutations
in African American colorectal cancer.
The researchers examined 66 patients who had stage I – III colorectal cancer and found those patients
positive for the mutations had an almost three times higher rate of metastatic disease, and stage III patients
positive with mutations were nearly three times more likely to relapse compared to patients without the mutations.
“This study is significant because it helps shed further light on why colorectal cancers are more
aggressive in African Americans compared to other groups,” said the study’s senior author Joseph E. Willis, MD,
Chief of Pathology at University Hospitals Case Medical Center and Professor of Pathology at Case Western
Reserve School of Medicine. “While mortality rates for Caucasian men with colorectal cancer have decreased by
up to 30 percent, they have increased by 28 percent for African American men since 1960,” said Dr. Willis, who is
also director of tissue management in the Case Comprehensive Cancer Center.
These findings and the earlier study only became possible because of technological advances in gene
sequencing and computational analysis. These studies ultimately involved review of 1.5 billion bits of data.
“This study builds on our previous genetic research on colorectal cancer,” said Sanford Markowitz, MD, PhD,
a co-author and principal investigator of the $11.3 million federal gastrointestinal cancers research program (GI
SPORE) that includes this project. ”It illustrates the extraordinary impact that dedicated, collaborative teams can
make when they combine scientific experience and ingenuity with significant investment.”
Announced in 2011, this GI SPORE program is one of just five in the country. Dr. Markowitz, Ingalls Professor
of Cancer Genetics at Case Western Reserve School of Medicine and a medical oncologist at UH Seidman
Cancer Center, included studies of the disease’s behavior in minority patients as part of his team’s original grant
application. The disparity between colorectal cancer rates in African Americans and other groups has long
existed; the most recent federal statistics, for example, put age-adjusted incidence at 46.8 cases for every
100,000 African Americans, and 38.1 cases for every 100,000 Caucasian Americans. Yet scientists have
struggled to determine what factors — biological, economic, environmental, or others — account for this disparity.
From the very start, Dr. Markowitz and colleagues believed the answer to this question would be found
through genetic analysis.
“Identifying gene mutations has been the basis of all the new drugs that have been developed to treat cancer
in the last decade,” Dr. Markowitz said. “Many of the new cancer drugs on the market today were developed to
target specific genes in which mutations were discovered to cause specific cancers.”
“We wondered if colon cancer is the same disease molecularly in African American individuals as it is in
Caucasian individuals. Or could colon cancer be the same disease behaving differently in one population
compared to another,” he said. “This study gave us our answer. Colon cancer in African American patients is a
different disease molecularly.”
The scientists made their discovery by using DNA sequencing to compare 103 colorectal cancer samples
from African American patients with 129 colorectal cancer samples from Caucasian patients, all of whom had
received care at UH Case Medical Center in Cleveland. The scientists examined 50 million bits of data from
20,000 genes in every cancer.
This research was supported by Public Health Service Awards Case GI SPORE P50 CA150964 and KO8
CA148980 and Career Development Program of Case GI SPORE Awards P50 CA150964; R21 CA149349, and
P30 CA043703. Substantial and generous gifts also came from the Marguerite Wilson Foundation, the Leonard
and Joan Horvitz Foundation, and the Richard Horvitz and Erica Hartman-Horvitz Foundation.
Other collaborating authors for this paper were Zhenghe Wang, PhD; Li Li, MD, PhD; Kishoe Guda, PhD;
Zhengyi Chen, PhD; Jill Barnholtz-Sloan, PhD; and Young Soo Park, PhD.
###
About Case Comprehensive Cancer Center
Case Comprehensive Cancer Center is an NCI-designated Comprehensive Cancer Center located at Case Western Reserve
University. The center, which has been continuously funded since 1987, integrates the cancer research activities of the largest
biomedical research and health care institutions in Ohio – Case Western Reserve, University Hospitals (UH) Case Medical
Center and the Cleveland Clinic. NCI-designated cancer centers are characterized by scientific excellence and the capability
to integrate a diversity of research approaches to focus on the problem of cancer. It is led by Stanton Gerson, MD, Asa and
Patricia Shiverick- Jane Shiverick (Tripp) Professor of Hematological Oncology, director of the National Center for
Regenerative Medicine, Case Western Reserve, and director of the Seidman Cancer Center at UH Case Medical Center.
About University Hospitals
Founded in May 1866, University Hospitals serves the needs of patients through an integrated network of 18
hospitals, more than 40 outpatient health centers and primary care physician offices in 15 counties throughout
Northeast Ohio. At the core of our $4 billion health system is University Hospitals Case Medical Center, ranked
among America’s best hospitals by U.S. News & World Report. The primary affiliate of Case Western Reserve
University School of Medicine, UH Case Medical Center is home to some of the most prestigious clinical and
research programs in the nation, including cancer, pediatrics, women's health, orthopedics, radiology,
neuroscience, cardiology and cardiovascular surgery, digestive health, transplantation and genetics. Its main
campus includes UH Rainbow Babies & Children's Hospital, ranked among the top children’s hospitals in the
nation; UH MacDonald Women's Hospital, Ohio's only hospital for women; and UH Seidman Cancer Center, part
of the NCI-designated Case Comprehensive Cancer Center at Case Western Reserve University. UH is the
second largest employer in Northeast Ohio with 26,000 employees. For more information, go to
www.UHhospitals.org.
About Case Western Reserve University School of Medicine
Founded in 1843, Case Western Reserve University School of Medicine is the largest medical research institution in Ohio and
is among the nation’s top medical schools for research funding from the National Institutes of Health. The School of Medicine
is recognized throughout the international medical community for outstanding achievements in teaching. The School’s
innovative and pioneering Western Reserve2 curriculum interweaves four themes--research and scholarship, clinical mastery,
leadership, and civic professionalism--to prepare students for the practice of evidence-based medicine in the rapidly changing
health care environment of the 21st century. Nine Nobel Laureates have been affiliated with the School of Medicine.
Annually, the School of Medicine trains more than 800 MD and MD/PhD students and ranks in the top 25 among U.S.
research-oriented medical schools as designated by U.S. News & World Report’s “Guide to Graduate Education.”
The School of Medicine’s primary affiliate is University Hospitals Case Medical Center and is additionally affiliated with
MetroHealth Medical Center, the Louis Stokes Cleveland Department of Veterans Affairs Medical Center, and the Cleveland
Clinic, with which it established the Cleveland Clinic Lerner College of Medicine of Case Western Reserve University in 2002.
http://casemed.case.edu